Multiple pathways counteract cell death induced by RB1 loss: Implications for cancer

Cell Cycle

Volumn 10, Issue 10, 2011, Pages 1533-1539

  Ciavarra, Giovanni ^a   Zacksenhaus, Eldad ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Autophagy; Bcl 2; Cancer; Cyclin D3; Hypoxia; Lithium; Mitochondria; Muscle degeneration; p107; p130; pRb; Skeletal myogenesis; Survival pathways

Indexed keywords

BECLIN 1; BETA CATENIN; BEZAFIBRATE; CHLOROQUINE; CYCLIN D3; HYPOXIA INDUCIBLE FACTOR 1; LITHIUM CHLORIDE; LONIDAMINE; MYOD PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; AUTOPHAGY; BIOGENESIS; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; GLYCOLYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN TENSION; PHAGOSOME; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TUMOR REGRESSION;

EID: 79956033147     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.10.15520     Document Type: Review

References (70)

1. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671-82.
2. Bremner R, Zacksenhaus E. Cyclins, Cdks, E2f, Skp2 and more at the first international RB Tumor Suppressor Meeting. Cancer Res 2010; 70:6114-8.
3. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005; 24:2796-809. (Pubitemid 40638091)
4. Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009; 9:785-97.
5. Ciavarra G, Zacksenhaus E. Direct and indirect effects of the pRb tumor suppressor on autophagy. Autophagy 2011; In press.
6. Vooijs M, Berns A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 1999; 18:5293-303. (Pubitemid 29462364)
7. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334:124-9.
8. McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology 2009; 384:335-44.
9. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994; 7:480-4. (Pubitemid 24308333)
10. Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22:1662-76. (Pubitemid 351846845)
11. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, et al. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest 2010; 120:3296-309.
12. Simpson MT, MacLaurin JG, Xu D, Ferguson KL, Vanderluit JL, Davoli MA, et al. Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice. J Neurosci 2001; 21:7089-98. (Pubitemid 32846956)
13. Ho A, Li H, Hakem R, Mak TW, Zacksenhaus E. Coupling of Caspase-9 to Apaf-1 in response to loss of pRb or cytotoxic drugs is cell type dependent. EMBO J 2004; 23:460-72. (Pubitemid 38294510)
14. Guo Z, Shi Y, Hiroki Y, Mak T, Zacksenhaus E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Research 2001; 61:8395-400. (Pubitemid 33131113)
15. Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008; 13:11-22. (Pubitemid 350309738)
16. Calo E, Quintero-Estades JA, Danielian PS, Nedelcu S, Berman SD, Lees JA. Rb regulates fate choice and lineage commitment in vivo. Nature 2010; 466:1110-4.
17. Scime A, Soleimani VD, Bentzinger CF, Gillespie MA, Le Grand F, Grenier G, et al. Oxidative status of muscle is determined by p107 regulation of PGC-1{alpha}. J Cell Biol 2010; 190:651-62.
18. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000; 407:592-8.
19. Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, Muscat GE, et al. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell 2001; 8:885-97. (Pubitemid 33030221)
20. MacLellan WR, Xiao G, Abdellatif M, Schneider MD. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol 2000; 20:8903-15. (Pubitemid 32245921)
21. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 2005; 18:623-35. (Pubitemid 40804799)
22. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 2001; 8:303-16. (Pubitemid 32831548)
23. Chen PL, Riley DJ, Chen-Kiang S, Lee WH. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 1996; 93:465-9. (Pubitemid 26038178)
24. Skapek SX, Pan YR, Lee EY. Regulation of cell lineage specification by the retinoblastoma tumor suppressor. Oncogene 2006; 25:5268-76. (Pubitemid 44299087)
25. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993; 72:309-24. (Pubitemid 23059403)
26. -/- muscle cells. Science 1994; 264:1467-71.
27. Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB. pRb is required for MEF2-dependent gene expression as well as cell cycle arrest during skeletal muscle differentiation. Curr Biol 1999; 9:449-59. (Pubitemid 29228617)
28. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 2010; 140:744-52.
29. Buckingham M. Making muscle in mammals. Trends Genet 1992; 8:144-8.
30. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993; 75:1351-9. (Pubitemid 24021909)
31. Olson EN, Klein WH. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 1994; 8:1-8. (Pubitemid 24032848)
32. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 1998; 14:167-96. (Pubitemid 29001453)
33. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, et al. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation and suppress tumor cell growth. Genes Dev 1998; 12:95-106. (Pubitemid 28083661)
34. Chen TT, Wang JY. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol Cell Biol 2000; 20:5571-80. (Pubitemid 30482892)
35. Jiang Z, Gou Z, Saad F, Ellis J, Zacksenhaus E. Retinoblastoma gene promoter directs transgene expression exclusively to the nervous system. J Biol Chem 2001; 276:593-600. (Pubitemid 32050356)
36. Zacksenhaus E, Jiang Z, Chung D, Marth J, Phillips RA, Gallie BL. pRb controls cell proliferation, differentiation and death of skeletal muscle cells and other lineages during embryogenesis. Genes & Dev 1996; 10:3051-64. (Pubitemid 26412531)
37. Huh MS, Parker MH, Scime A, Parks R, Rudnicki MA. Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J Cell Biol 2004; 166:865-76. (Pubitemid 39249837)
38. Ciavarra G, Zacksenhaus E. Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J Cell Biol 2010; 191:291-301.
39. Ciavarra G, Zacksenhaus E. Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J Cell Biol 2010; 191:291-301.
40. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008; 4:600-6.
41. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007; 27:6229-42. (Pubitemid 47326709)
42. Polager S, Ofir M, Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene 2008; 27:4860-4.
43. Ciavarra G, Ho A, Cobrinik D, Zacksenhaus E. Critical role of the Rb family in myoblast survival and fusion. Plos One 2011; 6:17682.
44. De Santa F, Albini S, Mezzaroma E, Baron L, Felsani A, Caruso M. pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation. Mol Cell Biol 2007; 27:7248-65. (Pubitemid 47549759)
45. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 6:1664-8. (Pubitemid 27050234)
46. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170:1101-11. (Pubitemid 41362642)
47. Sarkar S, Krishna G, Imarisio S, Saiki S, O'Kane CJ, Rubinsztein DC. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum Mol Genet 2008; 17:170-8.
48. Pasquali L, Busceti CL, Fulceri F, Paparelli A, Fornai F. Intracellular pathways underlying the effects of lithium. Behav Pharmacol 2010; 21:473-92.
49. Force T, Woodgett JR. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 2009; 284:9643-7.
50. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, et al. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008; 455:552-6.
51. Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, et al. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 2003; 100:4610-5. (Pubitemid 36457778)
52. Cenciarelli C, De Santa F, Puri PL, Mattei E, Ricci L, Bucci F, et al. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol 1999; 19:5203-17. (Pubitemid 29289558)
53. Xue L, Fletcher GC, Tolkovsky AM. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr Biol 2001; 11:361-5. (Pubitemid 32200740)
54. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-8. (Pubitemid 39625121)
55. White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 2010; 22:212-7.
56. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15:5308-16.
57. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25:460-70.
58. Ciavarra G, Zacksenhaus E. Direct and indirect effects of the pRb tumor suppressor on autophagy. Autophagy 2011; 7.
59. Jiang H, Martin V, Gomez-Manzano C, Johnson DG, Alonso M, White E, et al. The RB-E2F1 pathway regulates autophagy. Cancer Res 2010; 70:7882-93.
60. Bosco EE, Knudsen ES. RB in breast cancer: at the crossroads of tumorigenesis and treatment. Cell Cycle 2007; 6:667-71. (Pubitemid 46535677)
61. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Curr Opin Cell Biol 2010; 22:181-5.
62. Li B, Gordon GM, Du CH, Xu J, Du W. Specific killing of Rb mutant cancer cells by inactivating TSC2. Cancer Cell 2010; 17:469-80.
63. Hansen JB, Petersen RK, Larsen BM, Bartkova J, Alsner J, Kristiansen K. Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 1999; 274:2386-93.
64. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 2008; 22:463-75. (Pubitemid 351272754)
65. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33.
66. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15:6479-83.
67. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330:1340-4.
68. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85-95.
69. Darville MI, Antoine IV, Mertens-Strijthagen JR, Dupriez VJ, Rousseau GG. An E2F-dependent lateserum-response promoter in a gene that controls glycolysis. Oncogene 1995; 11:1509-17.
70. Perou CM. Molecular stratification of triple-negative breast cancers. Oncologist 2010; 15:39-48.